World's Best Scientists 2026 revealed!

D-Index & Metrics

Molecular Biology

D-Index
71
Citations
33128
World Ranking
1343
National Ranking
38

Reuven Agami publication distribution in Molecular Biology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Molecular Biology in 2026. The highlighted bar marks where Reuven Agami sits on this spectrum.

47–56 publications: 7 scientists 57–66 publications: 17 scientists 67–76 publications: 65 scientists 77–86 publications: 90 scientists 87–96 publications: 125 scientists 97–106 publications: 131 scientists 107–116 publications: 162 scientists 117–126 publications: 177 scientists 127–136 publications: 158 scientists 137–146 publications: 158 scientists 147–156 publications: 146 scientists 157–166 publications: 159 scientists 167–176 publications: 131 scientists 177–186 publications: 110 scientists 187–196 publications: 112 scientists 197–206 publications: 100 scientists 207–216 publications: 89 scientists 217–226 publications: 98 scientists 227–236 publications: 74 scientists 237–246 publications: 72 scientists 247–256 publications: 63 scientists 257–266 publications: 53 scientists 267–276 publications: 54 scientists 277–286 publications: 49 scientists 287–296 publications: 52 scientists 297–306 publications: 43 scientists 307–316 publications: 46 scientists 317–326 publications: 41 scientists 327–336 publications: 42 scientists 337–346 publications: 31 scientists 347–356 publications: 28 scientists 357–366 publications: 29 scientists 367–376 publications: 26 scientists 377–386 publications: 24 scientists 387–396 publications: 24 scientists 397–406 publications: 14 scientists 407–416 publications: 13 scientists 417–426 publications: 20 scientists 427–436 publications: 12 scientists 437–446 publications: 20 scientists 447–456 publications: 11 scientists 457–466 publications: 10 scientists 467–476 publications: 14 scientists 477–486 publications: 14 scientists 487–496 publications: 10 scientists 497–506 publications: 13 scientists 507–516 publications: 13 scientists 517–526 publications: 2 scientists 527–536 publications: 4 scientists 537–546 publications: 6 scientists 547–556 publications: 8 scientists 557–563 publications: 6 scientists 564+ publications: 100 scientists
47 publications 564+

This scientist: 161 publications — 43rd percentile

43% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 564 publications or more.

Reuven Agami D-index placement in Molecular Biology in 2026

The chart shows the D-index (discipline H-index) distribution of Molecular Biology scientists ranked by Research.com in 2026. The highlighted bar marks where Reuven Agami sits on this spectrum.

40–41 D-Index: 36 scientists 42–43 D-Index: 101 scientists 44–45 D-Index: 115 scientists 46–47 D-Index: 121 scientists 48–49 D-Index: 118 scientists 50–51 D-Index: 130 scientists 52–53 D-Index: 106 scientists 54–55 D-Index: 116 scientists 56–57 D-Index: 113 scientists 58–59 D-Index: 129 scientists 60–61 D-Index: 120 scientists 62–63 D-Index: 105 scientists 64–65 D-Index: 131 scientists 66–67 D-Index: 95 scientists 68–69 D-Index: 97 scientists 70–71 D-Index: 106 scientists 72–73 D-Index: 83 scientists 74–75 D-Index: 89 scientists 76–77 D-Index: 77 scientists 78–79 D-Index: 70 scientists 80–81 D-Index: 73 scientists 82–83 D-Index: 60 scientists 84–85 D-Index: 48 scientists 86–87 D-Index: 45 scientists 88–89 D-Index: 50 scientists 90–91 D-Index: 31 scientists 92–93 D-Index: 51 scientists 94–95 D-Index: 43 scientists 96–97 D-Index: 38 scientists 98–99 D-Index: 39 scientists 100–101 D-Index: 41 scientists 102–103 D-Index: 29 scientists 104–105 D-Index: 33 scientists 106–107 D-Index: 35 scientists 108–109 D-Index: 20 scientists 110–111 D-Index: 38 scientists 112–113 D-Index: 19 scientists 114–115 D-Index: 28 scientists 116–117 D-Index: 13 scientists 118–119 D-Index: 23 scientists 120–121 D-Index: 16 scientists 122–123 D-Index: 15 scientists 124–125 D-Index: 11 scientists 126–127 D-Index: 21 scientists 128–129 D-Index: 7 scientists 130–131 D-Index: 13 scientists 132–133 D-Index: 14 scientists 134–135 D-Index: 17 scientists 136–137 D-Index: 9 scientists 138–139 D-Index: 8 scientists 140–141 D-Index: 16 scientists 142–143 D-Index: 7 scientists 144 D-Index: 7 scientists 145+ D-Index: 100 scientists
40 D-Index 145+

This scientist: 71 D-Index — 57th percentile

57% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 145 D-Index or more.

Research.com Recognitions

  • 2016 - Member of Academia Europaea
  • Member of the European Molecular Biology Organization (EMBO)
  • Member of the European Molecular Biology Organization (EMBO)

Overview

Reuven Agami is affiliated with the Antoni van Leeuwenhoek Hospital in the Netherlands. Their research spans biochemistry, genetics, molecular biology, and medicine, with a focus on molecular biology, oncology, immunology, biological psychiatry, and cancer research. This multi-disciplinary approach emphasizes the intersections of RNA biology, cancer, and immune responses.

The scientist's recent papers cover a range of topics including tumor immunology, RNA dynamics, and cancer biology. Notable publications include:

  • Anti-tumour immunity induces aberrant peptide presentation in melanoma (2020, Nature)
  • Tryptophan depletion results in tryptophan-to-phenylalanine substitutants (2022, Nature)
  • Transcription Dynamics Regulate Poly(A) Tails and Expression of the RNA Degradation Machinery to Balance mRNA Levels (2020, Molecular Cell)
  • DNA damage induces p53-independent apoptosis through ribosome stalling (2024, Science)
  • Proteomic patterns associated with response to breast cancer neoadjuvant treatment (2020, Molecular Systems Biology)

Agami has frequently published in venues such as Molecular Cell, Nature, bioRxiv (Cold Spring Harbor Laboratory), Nature Communications, and Oncogene. This distribution indicates active involvement in both established journals and preprint platforms relevant to molecular biology and cancer research.

The scientist's main research topics include:

  • RNA modifications and cancer
  • RNA and protein synthesis mechanisms
  • RNA research and splicing
  • Peptidase inhibition and analysis
  • Immunotherapy and immune responses
  • Vaccines and immunoinformatics approaches
  • Tryptophan and brain disorders

Frequent collaborators in their work are Julien Champagne, Abhijeet Pataskar, Onno B. Bleijerveld, Pierre-René Körner, and Remco Nagel, reflecting a collaborative research environment with recurring partnerships.

Agami's contributions have been recognized through memberships in prominent scientific organizations, including the Academia Europaea since 2016 and the European Molecular Biology Organization (EMBO).

Best Publications

  • A System for Stable Expression of Short Interfering RNAs in Mammalian Cells

    Thijn R. Brummelkamp;René Bernards;Reuven Agami

  • Stable suppression of tumorigenicity by virus-mediated RNA interference.

    Thijn R Brummelkamp;René Bernards;Reuven Agami

  • A genetic screen implicates miRNA-372 and miRNA-373 as oncogenes in testicular germ cell tumors.

    P Mathijs Voorhoeve;Carlos le Sage;Mariette Schrier;Ad J M Gillis

  • A large-scale RNAi screen in human cells identifies new components of the p53 pathway

    Katrien Berns;E. Marielle Hijmans;Jasper Mullenders;Thijn R. Brummelkamp

  • The microRNAs miR-373 and miR-520c promote tumour invasion and metastasis

    Huang Q;Gumireddy K;Schrier M;le Sage C

  • Regulation of the p27Kip1 tumor suppressor by miR‐221 and miR‐222 promotes cancer cell proliferation

    Carlos le Sage;Remco Nagel;David A Egan;Mariette Schrier

  • RNA-binding protein Dnd1 inhibits microRNA access to target mRNA.

    Martijn Kedde;Markus J. Strasser;Bijan Boldajipour;Joachim A.F. Oude Vrielink

  • Alternative cleavage and polyadenylation: extent, regulation and function

    Ran Elkon;Alejandro P. Ugalde;Reuven Agami

  • Interaction of c-Abl and p73α and their collaboration to induce apoptosis

    Reuven Agami;Giovanni Blandino;Moshe Oren;Yosef Shaul

  • miR-148 targets human DNMT3b protein coding region.

    Anja M. Duursma;Martijn Kedde;Mariette Schrier;Carlos le Sage

  • MicroRNA regulation by RNA-binding proteins and its implications for cancer

    Marieke van Kouwenhove;Martijn Kedde;Reuven Agami;Reuven Agami

  • Specific inhibition of gene expression using a stably integrated, inducible small-interfering-RNA vector.

    Marc van de Wetering;Irma Oving;Vanesa Muncan;Menno Tjon Pon Fong

  • The PTEN-regulating microRNA miR-26a is amplified in high-grade glioma and facilitates gliomagenesis in vivo

    Jason T. Huse;Cameron Brennan;Dolores Hambardzumyan;Boyoung Wee

  • Regulation of the Adenomatous Polyposis Coli Gene by the miR-135 Family in Colorectal Cancer

    Remco Nagel;Carlos le Sage;Begoña Diosdado;Maike van der Waal

  • eRNAs are required for p53-dependent enhancer activity and gene transcription

    Carlos A. Melo;Carlos A. Melo;Jarno Drost;Patrick J. Wijchers;Harmen van de Werken

  • Deregulation of microRNA-503 Contributes to Diabetes Mellitus–Induced Impairment of Endothelial Function and Reparative Angiogenesis After Limb Ischemia

    Andrea Caporali;Marco Meloni;Christine Vollenkle;Desireee Bonci

  • A Pumilio-induced RNA structure switch in p27-3′ UTR controls miR-221 and miR-222 accessibility

    Martijn Kedde;Marieke van Kouwenhove;Wilbert Zwart;Joachim A F Oude Vrielink

  • Distinct initiation and maintenance mechanisms cooperate to induce G1 cell cycle arrest in response to DNA damage.

    Reuven Agami;René Bernards

  • Functional genetic screens for enhancer elements in the human genome using CRISPR-Cas9

    Gozde Korkmaz;Rui Lopes;Alejandro P Ugalde;Ekaterina Nevedomskaya

  • Survivin is required for a sustained spindle checkpoint arrest in response to lack of tension

    Susanne M.A. Lens;Rob M.F. Wolthuis;Rob Klompmaker;Jos Kauw

Frequent Co-Authors

Ran Elkon
Ran Elkon Tel Aviv University
René Bernards
René Bernards Antoni van Leeuwenhoek Hospital
Thijn R. Brummelkamp
Thijn R. Brummelkamp Antoni van Leeuwenhoek Hospital
Peter J.F. Snijders
Peter J.F. Snijders Vrije Universiteit Amsterdam
Giannino Del Sal
Giannino Del Sal University of Trieste
Yosef Shaul
Yosef Shaul Weizmann Institute of Science
Renske D.M. Steenbergen
Renske D.M. Steenbergen University of Amsterdam
Chris J.L.M. Meijer
Chris J.L.M. Meijer Vrije Universiteit Amsterdam
Elzo de Wit
Elzo de Wit Antoni van Leeuwenhoek Hospital
Manel Esteller
Manel Esteller Josep Carreras Leukaemia Research Institute

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring Molecular Biology can open doors to a range of online degree options and flexible careers in science and beyond. Whether you're seeking to add to your skillset or pivot into a different field, many accredited programs offer a pathway forward.

If you’re interested in sharpening analytical skills, consider enrolling in an online math bachelor's degree. For those with a flair for design and science, architect degree online programs can combine creativity with technical expertise.

Transitioning careers is also a viable option. For example, educators can make a rewarding shift by learning how to move from teacher to speech language pathologist. Additionally, creative thinkers might explore opportunities at graphic design schools online to break into visual communications.

Online degrees not only provide flexibility but also help you build a diverse skillset relevant to ever-evolving career landscapes. Take the first step toward a new professional chapter with these related programs.

Best Scientists Citing Reuven Agami

Trending Scientists

Recently Published Articles